Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Recommendations

Info

AIDS Vaccine 2012 PROGRAM AT A GLANCE Sunday, 9 September Monday, 10 September Tuesday, 11 September Wednesday, 12 September Registration BCEC Level 3, Ballroom Foyer | 08:00–14:00 Speaker Check-in BCEC Level 2, Room 251 | 07:30–12:30 Registration BCEC Level 3, Ballroom Foyer | 08:00–18:00 Speaker Check-in BCEC Level 2, Room 251 | 07:30–17:30 Registration BCEC Level 3, Ballroom Foyer | 07:30–18:00 Speaker Check-in BCEC Level 2, Room 251 | 07:30–17:30 Registration BCEC Level 3, Ballroom Foyer | 13:00–20:00 Speaker Check-in BCEC Level 2, Room 251 | 14:00–19:00 S08 Therapeutic Vaccination and Strategies for the Cure S07 Priming Effective B Cell Responses 08:30–10:00 PL02 A New Look at the Transmission Event Jacob Estes, Merlin Robb, Bette Korber PL01 HIV Vaccines in the Broader HIV Prevention Landscape Governor Deval L. Patrick, Anthony Fauci, Salim Karim, Jared Baeten, Mike Cohen 08:30–10:00 BCEC Level 3, Ballroom East | 08:30–10:00 BCEC Level 3, BCEC Level 2, 10:00–10:30 Tea and Coffee Break Ballroom East Room 253 ABC BCEC Level 3, Ballroom East | 08:30–10:30 10:00–10:30 BCEC Level 3, Ballroom Foyer l 10:00–10:30 08:30–10:00 08:30–10:00 10:30–11:00 Tea and Coffee Break Tea and Coffee Break 10:30–11:00 BCEC Level 3, Ballroom Foyer l 10:30–11:00 BCEC Level 3, Ballroom Foyer l 10:30–11:00 OA01 OA02 OA03 OA07 OA08 OA09 Animal Models Vaccine Concepts Innate Immunity B Cell Responses T Cell Responses Clinical Trials PL03 – Protein Immunogens New Concepts in Immune Induction 11:00–12:30 Richard Koup, Barton Haynes, Silke Paust 11:00–12:30 Satellite Sessions 08:30–16:00 BCEC Level 2, BCEC Level 3, BCEC Level 2, BCEC Level 3, BCEC Level 2, BCEC Level 2, Detailed descriptions are located Room 253 ABC Ballroom East Room 258 ABC Ballroom East Room 258 ABC Room 253 ABC 11:00–12:30 11:00–12:30 11:00–12:30 BCEC Level 3, Ballroom East | 11:00–12:30 on pages 9–12 of the program book. 10:30–12:30 10:30–12:30 10:30–12:30 Lunch Lunch Rapporteurs BCEC Level 2, Rooms 252 AB / 254 AB / 257 AB | 12:30–13:30 BCEC Level 2, Rooms 252 AB / 254 AB / 257 AB | 12:30–13:30 12:30–13:30 Morgane Rolland, Magdalena Sobieszczyk, 12:30–13:30 Networking Lunch Networking Lunch Julie Boucau, Nichole Klatt BCEC Level 2, Room 259 AB | 12:30–13:30 BCEC Level 2, Room 259 AB | 12:30–13:30 BCEC Level 3, Ballroom East | 12:30–13:30 Closing and Handover OA04 OA05 OA06 OA10 OA11 OA12 13:30–14:00 Bill Snow, Galit Alter, Dan Barouch, Jose Gatell, Mucosal Social/Ethical V1/V2 Antibody HIV Transmission/ Vaccine Vaccine Concepts 13:30–14:00 Bonaventura Clotet Immunity Issues Responses Diversity Immunogens/ – Vectors and BCEC Level 3, Ballroom East | 13:30–14:00 Delivery Inserts 13:30–14:45 BCEC Level 2, BCEC Level 2, BCEC Level 3, BCEC Level 2, BCEC Level 3, BCEC Level 2, 13:30–14:45 Room 258 ABC Room 253 ABC Ballroom East Room 258 ABC Ballroom East Room 253 ABC 13:30–14:45 13:30–14:45 13:30–14:45 13:30–14:45 13:30–14:45 13:30–14:45 Poster Session 1 with Poster Session 2 with Satellite Sessions 14:45–16:00 Tea and Coffee Break Tea and Coffee Break 14:00–17:00 14:45–16:00 BCEC Level 3, Ballroom West | 14:45–16:00 BCEC Level 3, Ballroom West | 14:45–16:00 Detailed descriptions are located on page 13 of the program book. 16:00–16:30 S01 S02 S03 S04 S05 S06 16:00–16:30 Exploiting the Lessons from New Env Cross- -cutting Mucosal Preclinical Studies Innate Immune Clinical Trials Immunogens Issues in Clinical Immunology and Vaccine Response Trial Design Platforms Opening Session 13:30–18:00 16:30–18:00 Galit Alter, Dan Barouch, Bill Snow, BCEC Level 2, BCEC Level 2, BCEC Level 3, BCEC Level 2, BCEC Level 2, BCEC Level 3, Mayor Thomas M Menino, Paul Farmer, Room 258 ABC Room 253 ABC Ballroom East Room 253 ABC Room 258 ABC Ballroom East Trevor Mundel 16:00–18:00 16:00–18:00 16:00–18:00 16:00–18:00 16:00–18:00 16:00–18:00 18:00–18:30 18:00–18:30 Poster Session 3 and BCEC Level 3, Ballroom East | 16:30–18:30 Banquet at the Seaport World Trade Center Reception Welcome Reception 18:30–20:00 18:30–20:00 BCEC Level 3, Ballroom Foyer | 18:30–20:00 18:30–23:00 BCEC Level 3, Ballroom West | 18:00–20:00
ABSTRACT BOOK 9 – 12 September 2012 Boston, Massachusetts, USA www.VaccineEnterprise.org http://cfar.globalhealth.harvard.edu www.ragoninstitute.org/index.html Abstracts will be published as an online supplement in Retrovirology. Abstracts will be open access at http://www.retrovirology.com/supplements/9/S2 at the conclusion of the conference on Wednesday, 12 September. Faneuil Hall image courtesy of freefoto.com, Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Page 4 and 5: AIDS Vaccine 2012 Partners www.alli
Page 6 and 7: CONFERENCE ORGANIZERS Conference Or
Page 8 and 9: CONFERENCE ORGANIZERS Conference Or
Page 10 and 11: SCHOLARSHIP RECIPIENTS Awards and S
Page 12 and 13: SCHOLARSHIP RECIPIENTS Awards and S
Page 14 and 15: PROGRAM / MONDAY 2 Program Monday,
Page 16 and 17: PROGRAM / MONDAY 4 Program 11:00 -
Page 22 and 23: PROGRAM / TUESDAY 10 Program Tuesda
Page 24 and 25: PROGRAM / TUESDAY 12 Program 11:45
Page 26 and 27: PROGRAM / TUESDAY 14 Program 13:30
Page 28 and 29: PROGRAM / TUESDAY 16 Program Poster
Page 30 and 31: PROGRAM / TUESDAY 18 Program AIDS V
Page 32 and 33: PROGRAM / WEDNESDAY 20 Program Wedn
Page 34 and 35: 22 AIDS Vaccine 2012
Page 36 and 37: PLENARY SESSIONS 24 Plenary Session
Page 42 and 43: SYMPOSIA SESSIONS 30 Symposia Sessi
Page 52 and 53:
SYMPOSIA SESSIONS 40 Symposia Sessi
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
ORAL ABSTRACT SESSIONS 54 Oral Abst
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
92 AIDS Vaccine 2012
Page 106 and 107:
POSTERS 94 AIDS Vaccine 2012
Page 108 and 109:
POSTERS 96 Posters Topic 1: Adjuvan
Page 110 and 111:
POSTERS 98 Posters Topic 1: Adjuvan
Page 112 and 113:
POSTERS Posters Topic 1: Adjuvants,
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
POSTERS Posters Topic 2: Animal Mod
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
POSTERS Posters Topic 3: B Cell Imm
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
POSTERS Posters Topic 4: Clinical V
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
POSTERS Posters Topic 5: HIV Transm
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
POSTERS Posters Topic 6: Immunogene
Page 192 and 193:
POSTERS Posters Topic 7: Innate Imm
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
POSTERS Posters Topic 8: Mucosal Im
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
POSTERS Posters Topic 9: Non-Vaccin
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
POSTERS Posters Topic 10: Social/Et
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
POSTERS Posters Topic 11: T Cell Im
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
POSTERS Posters Topic 12: Vaccine C
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
POSTERS Posters Topic 13: Pediatric
Page 290 and 291:
AUTHOR INDEX Author Index Brander,
Page 292 and 293:
AUTHOR INDEX Author Index Guan, Y .
Page 294 and 295:
AUTHOR INDEX Author Index Lucas, J.
Page 296 and 297:
AUTHOR INDEX Author Index Quinn, T
Page 298 and 299:
AUTHOR INDEX Author Index Wendel-Ha
Page 300 and 301:
Notes 288
Page 302 and 303:
Notes 290
Page 305:
Poster Session 1 - Monday, 10 Septe
show all

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Create successful ePaper yourself

Delete template?

Save as template?